Ascent Therapeutics Company
Ascent Therapeutics offers Pepducins targeting GPCRs on the cell membrane, expanding the GPCR frontier.
Employee Number:
1-10
Funding Status:
Early Stage Venture
Headquarters:
Cambridge, Massachusetts, United States
Technology:
Anti-infective Drugs
Estimated Revenue:
$1M to $10M
Founded Date:
2006
Industry:
PharmTech